Related Experiment Videos
Pediatric lung transplantation.
1Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, Missouri 63110, USA. huddlestonc@wustl.edu
Seminars in Pediatric Surgery
|July 5, 2006
Summary
Pediatric lung transplantation offers a vital survival option for children with severe lung diseases like cystic fibrosis. However, long-term survival remains around 50% due to complications such as bronchiolitis obliterans and infections.
Area of Science:
- Pediatric surgery
- Pulmonology
- Transplant medicine
Background:
- Lung transplantation in children has been performed since the early 1990s.
- Indications include cystic fibrosis, pulmonary vascular disease, and other fatal pediatric pulmonary conditions.
- Specific conditions involve metabolic abnormalities causing severe respiratory insufficiency in newborns.
Purpose of the Study:
- To review the outcomes and challenges of pediatric lung transplantation.
- To highlight the critical role of transplantation in life-threatening pediatric lung diseases.
- To identify major causes of mortality and potential future improvements.
Main Methods:
- Review of clinical data and outcomes for pediatric lung transplant recipients.
- Analysis of indications for transplantation.
- Identification of post-transplant complications and mortality causes.
Main Results:
- Pediatric lung transplantation provides a last resort for survival in many cases.
- Long-term survival rates are approximately 50% at 5 years.
- Major late mortality causes include bronchiolitis obliterans, infections, and malignancy.
Conclusions:
- Despite significant challenges, lung transplantation remains a crucial option for pediatric patients with end-stage lung disease.
- Improving immunosuppression strategies and managing post-transplant complications are key to enhancing long-term outcomes.
- Further research into novel immunosuppressants may improve survival rates in the future.